Finally, the expression and activation of Src has recently emerged as a potential mediator of resistance to EGFR inhibitors [15] [16] [17] .
The mechanism underlying the functional interaction between EGFR and Src is poorly understood; however, it has been proposed to be dependent, in part, on Src-mediated phosphorylation of Tyr845 of EGFR 6, 7 . Tyr845 is in the activation loop of EGFR, and phosphorylation at homologous residues in other tyrosine kinases is generally required for activation 18 . However, phosphorylation of Tyr845 is not required for EGFR's catalytic activity or EGF-induced activation of the Ras-MAPK pathway 6, 19 . In addition, Src-mediated activation, compared to EGF-mediated activation, affects only a subset of EGFR functions and correlates with a different pattern of downstream protein phosphorylation 8, 20 . These results suggest that additional mechanisms underlie the ability of Src to augment the selective aspects of EGFR function.
To further investigate the functional interaction between EGFR and Src, we used a peptide library approach to examine their substrate specificities. Surprisingly, we found that EGFR preferentially phosphorylates substrates with a phosphotyrosine at the +1 position relative to the phosphorylation site. We identified several candidate EGFR-phosphorylation sites, including Tyr239 of the adaptor protein Shc1, that have a phosphotyrosine at the +1 position in vivo. Using synthetic peptides based on the sequence surrounding Tyr239 of Shc1, we found that Src preferentially phosphorylates Tyr240 and thereby promotes subsequent phosphorylation of Tyr239 by EGFR. We also found that, compared to the singly phosphorylated peptides, the doubly phosphorylated Shc1 peptide binds more tightly to Grb2, in a a r t i c l e s key step in activating the Ras-MAPK pathway. Finally, we determined the crystal structure of the EGFR kinase domain in complex with a Shc1 peptide 'primed' at Tyr240, thus revealing the structural basis for EGFR substrate specificity. Together, these results uncover a previously undescribed characteristic of EGFR signaling that contributes to the functional synergy between EGFR and Src.
RESULTS

Determination of the EGFR optimal substrate motif
To determine the substrate specificity of EGFR, we used a positional scanning peptide library (PSPL) approach 21 . The PSPL approach uses a set of 198 biotinylated peptide libraries, each containing a tyrosine fixed at the central position and one additional amino acid fixed at flanking positions (Fig. 1a ). An advantage of the PSPL approach, as compared to other methods used to profile kinase substrate specificity, is that phosphorylated amino acids are also fixed at the flanking positions, thus enabling the identification of kinases whose specificity determinants include a priming phosphorylation. The other positions in each library contain a degenerate mixture of all amino acids, excluding cysteine and tyrosine.
We simultaneously phosphorylated the peptide libraries in solution, using recombinant EGFR kinase domain and [γ-32 P]ATP. We then spotted aliquots of each reaction in parallel on a streptavidin-coated membrane and determined the relative preference for each amino acid at each position according to the level of radiolabel incorporation into the corresponding peptides. Unexpectedly, we found that EGFR had a strong preference for phosphotyrosine at the +1 position relative to the phosphorylation site (Fig. 1b) . The remaining positions were less important for EGFR substrate recognition, and there was a minor preference for acidic amino acids at several positions N terminal to the central tyrosine, in agreement with previous studies 22 . We also determined the optimal substrate motif for the L858R mutant of EGFR, which is found frequently in NSCLC 23 . Because this mutation lies in the activation loop of the kinase domain, a region critical for binding of substrates, it could potentially alter EGFR substrate specificity. However, we found that the L858R mutant had a motif essentially identical to that of wild-type EGFR (Fig. 1b) . Phosphorylation of the peptide library with phosphotyrosine at the +1 position was blocked by the EGFR-specific inhibitor gefitinib, thus confirming that the results were not due to a contaminating kinase (Supplementary Fig. 1 ). We averaged data from three independent peptide library assays to generate a consensus EGFR phosphorylation motif ( Fig. 1c and Supplementary Table 1) .
Identification of candidate EGFR-phosphorylation sites
The PSPL results suggested that cellular substrates of EGFR are likely to have a phosphotyrosine one position C terminal to the phosphorylation site. For EGFR, as for other receptor tyrosine kinases, the primary cellular substrate is the receptor itself. Ligand binding induces EGFR dimerization and autophosphorylation of tyrosine residues in the intracellular region of the receptor, and these phosphorylated tyrosines serve as docking sites for effector molecules. The docked effector molecules, as well as other cytoplasmic proteins, can also be phosphorylated by EGFR, thus linking the activated receptor to downstream signaling pathways. The intracellular region of EGFR does not contain any Y-Y sequences; therefore, the optimal phosphorylation motif determined in the peptide library is likely to be a determinant of EGFR specificity for downstream substrates rather than autophosphorylation.
To identify potential downstream substrates with a phosphotyrosine one position C terminal to the predicted phosphorylation site, we used PhosphoSitePlus (http://www.phosphosite.org/), a database of experimentally observed post-translational modifications from Cell Signaling Technologies 24 . We searched the database to find tyrosine phosphorylation sites that are sensitive to treatment with EGFRspecific inhibitors and have a phosphotyrosine at the +1 position. Interestingly, many of the predicted phosphorylation sites occur in proteins with known roles in EGFR signaling ( Table 1) . However, of these predicted substrates, only Shc1 has been reported to be directly phosphorylated by EGFR 25 . Shc1 is an adaptor protein that integrates the activity of various signaling proteins, including receptor tyrosine kinases, cytoplasmic kinases, integrins and G protein-coupled receptors, with the Ras-MAPK pathway 26 . Phosphorylation of Shc1 at Tyr239 creates a pTyr-X-Asn-X-motif (in which X represents any amino acid, and p represents phosphorylation), a binding site for the SH2 domain of Grb2, thus leading to activation of the Ras-MAPK pathway 27, 28 .
To test whether prior phosphorylation also enhances EGFR activity toward the identified candidate substrates, we generated synthetic peptides corresponding to the sequences surrounding the predicted Shc1 and MET phosphorylation sites ( Table 1 ). In agreement with the PSPL results, both peptides were substantially better substrates npg a r t i c l e s for EGFR when the tyrosine at the +1 position was phosphorylated ( Fig. 2a and Supplementary Fig. 2 ).
EGFR phosphorylation of Shc1 is enhanced by a priming kinase
Although EGFR has been reported to regulate the phosphorylation of Tyr239 and Tyr240 of Shc1, whether one or both sites are directly phosphorylated by EGFR has not been examined 25 . The above results showed that EGFR phosphorylation of the Shc1 peptide at Tyr239 is enhanced by phosphorylation at Tyr240. This coordinated regulation could result if EGFR were to sequentially phosphorylate both sites. In this scenario, EGFR would phosphorylate the unmodified substrate at Tyr240 with low efficiency. After the initial phosphorylation, the substrate would be activated for subsequent phosphorylation at Tyr239. A similar mechanism has been proposed for SR protein kinase 1, which 'primes' and then sequentially phosphorylates arginine-serine dipeptide repeats in RS-domain proteins 29 . In agreement with this possible mechanism, EGFR had weak but detectable activity toward the unmodified Shc1 peptide (Fig. 2a) . Alternatively, a different kinase may prime Shc1 at Tyr240, thus enhancing EGFR phosphorylation of Tyr239.
To determine which mechanism best explains EGFR phosphorylation of Shc1, we analyzed the product of EGFR phosphorylation of the unmodified Shc1 peptide by HPLC and tandem mass spectrometry (LC-MS/MS). If EGFR were to sequentially phosphorylate both sites, the initial product generated would be expected to be peptides phosphorylated at Tyr240. Over time, the doubly phosphorylated product would then accumulate. If a different kinase were to prime Shc1, the product generated would be peptides phosphorylated at Tyr239, and the doubly phosphorylated product should not be detected.
To analyze the reaction between EGFR and the unmodified Shc1 peptide, we first synthesized the three possible product peptides: the product of phosphorylation at Tyr239 (pY-Y), the product of phosphorylation at Tyr240 (Y-pY) and the product of phosphorylation at both sites (pY-pY). We then determined retention times for each product peptide and the substrate peptide (Y-Y) by reversed-phase HPLC. Although we achieved complete separation between the substrate, monophosphorylated and doubly phosphorylated peptides, both monophosphorylated peptides (pY-Y and Y-pY) had the same retention time (Fig. 2b) . We then monitored aliquots of an in vitro kinase reaction containing EGFR and the unphosphorylated Shc1 peptide at different time points under the same HPLC conditions. Even after 2 h, monophosphorylated peptides were the only product detected (Fig. 2c) . To determine whether the monophosphorylated product generated was peptide phosphorylated at Tyr239, peptide phosphorylated at Tyr240 or a mixture of both, we collected the monophosphorylated peak and analyzed it by LC-MS/MS. Of all the phosphopeptide spectra identified by LC-MS/MS in the npg a r t i c l e s monophosphorylated peak (>50 spectra), 100% were phosphorylated at Tyr239 (Fig. 2d,e) . We detected no peptides phosphorylated at Tyr240 after rigorous inspection of the fragment ions. Moreover, the peptide phosphorylated at Tyr239 (pY-Y) was a very unfavorable substrate for phosphorylation by EGFR (Fig. 2a) . Together, these results are consistent with a mechanism wherein EGFR specifically phosphorylates Tyr239 of Shc1, and phosphorylation of Tyr240 by a different kinase enhances this activity. Because the peptide phosphorylated at Tyr239 is not a substrate for further phosphorylation by EGFR (because we detected no pY-pY peptides previously; Fig. 2c ), the reaction with the Shc1 peptide can be assumed to follow a standard Michaelis-Menten mechanism. Therefore, we compared the K m and k cat values for EGFR phosphorylation of the unmodified peptide with those of the peptide primed at Tyr240. The rate constants (k cat ) were similar for both peptides ( Table 2) . However, the priming phosphorylation decreased the K m for the peptide by approximately four-fold.
Src primes Shc1 for EGFR phosphorylation
The results presented above suggested that prior phosphorylation by a priming kinase enhances EGFR activity toward Shc1 and potentially other substrates. We were therefore interested in identifying the kinase, or kinases, responsible for the priming phosphorylation. In the case of Shc1, Src has been previously reported to coordinately phosphorylate both Tyr239 and Tyr240 (refs. 25,27) . Hence, we decided to further determine whether Src sequentially phosphorylates both sites or preferentially phosphorylates Ty239 or Tyr240. First, we examined the substrate specificity of Src with the PSPL assay. Src was considerably less specific than EGFR and displayed activity toward many of the peptides in the PSPL assay (Fig. 3a) . Src had strong preferences for acidic residues in the −3 position; hydrophobic residues, especially isoleucine, at the −1 position; and aromatic residues at the +3 position (Supplementary Table 2 ). Interestingly, tyrosine was a relatively strong selection at several positions relative to the phosphorylation site (particularly +3 and −3), a result consistent with a potential role for Src in priming substrates (Fig. 3a) . Src treated with the Src-family inhibitor dasatinib did not exhibit selectivity at these positions, thus confirming that the results were not due to a contaminating kinase (Supplementary Fig. 1) .
We then tested Src activity toward the unmodified and phosphorylated peptides corresponding to the sequence surrounding Tyr239 of Shc1. Src phosphorylated each peptide. However, in contrast to the results for EGFR, the unphosphorylated Shc1 peptide was a better substrate for Src than peptides with either Tyr239 or Tyr240 already phosphorylated (Fig. 3b) . To determine which sites on the unmodified Shc1 peptide were phosphorylated by Src, we monitored aliquots of the reaction at different time points, using the same HPLC conditions as in the analysis of EGFR specificity. Similarly to the results with EGFR, monophosphorylated peptides were the predominant product of the reaction with Src (Fig. 3c) . MS analysis of the monophosphorylated peak indicated that 95% of all phosphopeptide spectra detected were phosphorylated at Tyr240 (Fig. 3d,e) . 
Only when both Src and EGFR were included in the reaction was the peptide phosphorylated at both Tyr239 and Tyr240 (Fig. 3f) . Together, these results suggest that Src phosphorylates Tyr240 of Shc1, priming it for phosphorylation at Tyr239 by EGFR.
Phosphorylation of Tyr239 enhances Shc1 binding to Grb2
To determine whether Src and EGFR coordinately phosphorylate Tyr240 and Tyr239 of Shc1 in cells, we used phosphospecific anti-Shc, which detects only Shc1 phosphorylated at both sites ( Supplementary  Fig. 3 ). When we stimulated MCF10A cells, which have high Src activity, with EGF, we detected substantial phosphorylation of both Tyr239 and Tyr240 (Fig. 4a) . However, when we blocked Src activity with the Src inhibitor dasatinib, the dual phosphorylation induced by EGF was almost completely abolished (Fig. 4a) . These results are consistent with our in vitro data and indicate that the combined activities of Src and EGFR generate doubly phosphorylated Shc1 in cells. As discussed above, it is well established that Src activity augments MAPK signaling initiated by EGFR 5 . For example, cells in which both Src and EGFR are overexpressed or coactivated show a synergistic increase in total Shc phosphorylation, Shc1-Grb2 binding and MAPK activation 10, 11, 30 . Our results suggested that one mechanism by which Src can enhance EGF-induced MAPK signaling is by phosphorylating Tyr240 of Shc1, thereby promoting EGFR phosphorylation of Tyr239. A potential second mechanism could be by enhancing the phosphorylation-induced interaction between Shc1 and Grb2. To test this possibility, we generated synthetic peptides corresponding to phosphorylated Tyr239 and Tyr240 of Shc1. We immobilized the peptides and incubated them with cell lysates, and then detected Grb2 binding to each peptide by immunoblotting (Fig. 4b) . As expected, the peptide phosphorylated at Tyr239 (pY-Y) bound Grb2, whereas the peptide phosphorylated at Tyr240 (Y-pY, which lacks the pTyr-X-Asn-X Grb2-binding motif) did not bind Grb2. Importantly, the peptide phosphorylated at both Tyr239 and Tyr240 (pY-pY) bound significantly more Grb2 than the peptide phosphorylated at Tyr239 alone (Fig. 4b) . In agreement with this observed enhancement in the interaction between Shc1 and Grb2, generation of doubly phosphorylated Shc1 correlated with enhanced MAPK activation in cells (Fig. 4a) .
A crystal structure of Grb2 in complex with a pseudopeptide based on the sequence of Shc1 doubly phosphorylated at Tyr239 and Tyr240 has been reported 31 . In the structure, the phosphate of phosphorylated Tyr240 makes several interactions with the Grb2 SH2 domain (Fig. 4c) . These interactions confer a three-fold increase in the affinity of doubly phosphorylated Shc1 for Grb2, as compared to the affinity npg a r t i c l e s when Tyr239 alone is phosphorylated 31 . Together, these results indicate that Src and EGFR coordinately regulate the phosphorylation of Shc1 Tyr240 and Tyr239 in cells, and the dual phosphorylation enhances the ability of Shc1 to bind Grb2 (Fig. 4d) .
Structural basis for EGFR substrate specificity
In order to identify the molecular basis for EGFR's substrate specificity, we determined the crystal structure of the EGFR L858R kinase domain in complex with the Shc1 peptide primed at Tyr240 (PDHQYpYNDF; crystallographic and refinement statistics in Table 3 ). As in those of other protein kinases, the kinase domain of EGFR has an N-terminal lobe comprising an antiparallel β-sheet and single α-helix (C helix), and a C-terminal lobe that is predominantly α-helical (Fig. 5a ). The activation loop (A loop) lies near the interface of the two lobes and provides part of the platform for peptide binding (discussed below). In the structure of the EGFR-Shc1 peptide complex, several Shc1 peptide residues (proline at position -4, aspartate at position −3 and phenylalanine at position +4) did not have well-defined electron density and are not included in the model (Supplementary Fig. 4) . The Shc1 peptide binds in an extended conformation to the C lobe and A loop of EGFR, similarly to the mode of substrate binding in other protein kinase-peptide substrate complexes (Fig. 5a) . A short, antiparallel β-strand interaction is formed between the peptide and the C-terminal segment of the A loop. Four hydrogen bonds are formed between the Shc1 peptide backbone at positions −1 to +3 and the main chain of the EGFR kinase domain from residues Gly874 to Ile878. The hydroxyl oxygen of Tyr239 (Y0) is hydrogen-bonded to Asp837, the catalytic base, and is in position for phosphoryl transfer. Surprisingly, the only other sequence-specific interaction observed between EGFR and the Shc1 peptide occurred with phospho-Tyr240 (pY+1). The phosphate group binds the ε-amino nitrogen of Lys879 and the main chain nitrogen of Ala920 (Fig. 5b) . The binding site formed by Lys879 and Ala920 in the EGFR is only weakly basic, in agreement with the observation that phosphorylation of Tyr240 enhances, but is not required for, EGFR activity.
The position equivalent to EGFR Lys879 is conserved in the other active members of the ERBB family of receptor tyrosine kinases, ERBB2 and ERBB4. We therefore tested whether ERBB2 and ERBB4, like EGFR, have specificity for primed substrates. Using the PSPL assay, we found that both ERBB2 and ERBB4 also had a strong preference for phosphotyrosine at the +1 position relative to the phosphorylation site (Supplementary Fig. 5) .
We also determined the crystal structure of the EGFR kinase domain in complex with a substrate peptide with the optimal sequence, as determined in the PSPL assay. In addition to the strong selection for phosphotyrosine at the +1 position, EGFR has weak preferences for acidic residues, particularly N terminal to the phosphorylation site, and hydrophobic residues, particularly at the +3 position ( Fig. 1 and Supplementary Table 1) . The optimal substrate peptide (DEEDYpYEIP) binds to the EGFR kinase domain in a mode nearly identical to that observed with the Shc1 peptide, with the phosphotyrosine at the +1 position forming interactions with the ε-amino nitrogen of Lys879 and the main chain nitrogen of Ala920 (Supplementary Fig. 4) . Surprisingly, despite the use of an optimized sequence, we observed only one additional substrate side chain interaction between the aspartate at position −1 and Arg841 of EGFR. In previously reported structures of tyrosine kinase domains in complex with substrate peptides (for example IRK, IGF1R and ABL), hydrophobic contacts between amino acids C terminal to the phosphorylation site and hydrophobic pockets on the surfaces of the enzymes have been the predominant interactions observed [32] [33] [34] . Although the surface of EGFR has a structurally equivalent hydrophobic pocket (formed from the side chains of Val876, Ile878 and Ile886), the isoleucine at the +3 position of the optimal substrate peptide did not have well-defined electron density. These structural observations further suggest that, other than the phosphotyrosine at +1, the primary sequence surrounding the phosphorylation site may have little influence on EGFR specificity.
DISCUSSION
Cooperativity with Src is a key element of EGFR signaling with an important functional role in EGFR-driven cancers; however, the underlying mechanism is poorly understood. Here, we provide a molecular explanation for how Src activity is integrated with EGFR signaling. We found that EGFR preferentially phosphorylates substrates that are primed by a prior phosphorylation and, in the case of the adaptor protein Shc1, we showed that Src mediates the priming phosphorylation. Importantly, the dual phosphorylation of Shc1 by Src and EGFR significantly enhanced Shc1 binding to Grb2, a key step in activating the Ras-MAPK pathway, beyond the level associated with binding of Shc1 singly phosphorylated by EGFR alone (Fig. 4d) .
Evidence that EGFR selectivity for phosphotyrosine-primed substrates is relevant in cells has come from the observation that many tyrosine phosphorylation sites in cells driven by EGFR mutations have a phosphotyrosine at the +1 position 35 . We used the PhosphoSitePlus database to identify a subset of these sites that have also been shown to be sensitive to treatment with EGFR-specific inhibitors ( Table 1 ). In the case of Shc1 Tyr239, we showed that Src can function as the priming kinase and catalyze the priming phosphorylation at Tyr240. However, it is likely that Src primes multiple substrates for EGFR phosphorylation. For example, a recent study has shown that EGFR phosphorylation of Mig6, a putative tumor suppressor and feedback inhibitor of EGFR, is enhanced by prior phosphorylation of an adjacent tyrosine by Src 36 . If Src primes multiple EGFR substrates, it will be important to determine whether this is a mechanism by which Src promotes signaling through a subset of pathways downstream of EGFR or whether Src induces the phosphorylation of a different set of substrates.
The crystal structure of the EGFR kinase domain in complex with a Shc1 peptide phosphorylated at Tyr240 provides a molecular explanation for EGFR's specificity for primed substrates. Interestingly, npg a r t i c l e s in both this structure and a structure of EGFR in complex with an optimized substrate peptide, the major sequence-specific interaction was between EGFR and the phosphate of the phosphotyrosine at position +1 ( Fig. 5 and Supplementary Fig. 4 ). This observation suggests that prior phosphorylation, rather than the sequence of the surrounding amino acids, is the dominant sequence feature recognized by EGFR. A lack of stringent primary-sequence requirements suggests that EGFR has the potential to phosphorylate substrates primed by many different tyrosine kinases, and this function might serve as a mechanism of signal integration with multiple signaling pathways.
In the case of Shc1, we showed that Src preferentially phosphorylates Tyr240, thereby promoting EGFR phosphorylation of Tyr239. However, our PSPL results indicated that Src has relatively strong selectivity for tyrosine at several positions surrounding the phosphorylation site (Fig. 3a) . These results suggest that Src could potentially catalyze priming phosphorylations at multiple positions flanking tyrosine phosphorylation sites. Substrate priming may therefore be a general characteristic of Src signaling and may be the mechanism by which Src participates in signaling downstream of several receptor tyrosine kinases 5 .
Our current work indicates that the SH2 domain of Grb2 binds to doubly phosphorylated Shc1 with greater affinity than to Shc1 phosphorylated at Tyr239 alone (Fig. 4b) . We previously investigated the optimal binding motif for the Grb2 SH2 domain 28 . We found that asparagine at the +2 position (relative to pY239 of Shc1) dominated the binding selectivity, and subsequent work elucidated the structural basis for this specificity 37 . However, our original study investigated selectivity for only the 20 natural amino acids; we did not address selectivity for phosphorylated amino acids within the optimal binding motif. Our current results, together with those of several recent studies showing increased affinity of SH2 domains for doubly phosphorylated peptides, raise the possibility that the presence of multiple phosphorylations within an SH2 domain-recognition motif may be a common mechanism that enables complex regulation of SH2 domain-target protein interactions [38] [39] [40] [41] .
Finally, it is well established that the substrate selectivity of protein kinases is strongly influenced by the sequence immediately surrounding the phosphorylation site. Until recently, selectivity for phosphorylated amino acids was thought to be unique to the serine/threonine protein kinases glycogen synthase kinase-3 and casein kinase 1 (refs. 42,43) . However, recent high-resolution phosphoproteomics analyses have made it clear that the sequences surrounding phosphorylation sites often contain additional sites of phosphorylation 44 . For example, a survey of multiply phosphorylated proteins has shown that more than half of all phosphorylation sites are within four amino acids of another site 45 . On the basis of these observations, proximal phosphorylations would be expected to be an important selectivity determinant for far more protein kinases. One explanation for why so few kinases with this selectivity have been identified is that phosphorylated amino acids had to be excluded from previous methods used to determine protein kinase selectivity in vitro. Concordantly, recent studies using the PSPL approach have identified several additional kinases with selectivity for phosphorylated substrates [46] [47] [48] [49] . These observations, together with results described here, suggest that coordinated substrate phosphorylation by two or more kinases is likely to be a common mechanism of signal integration that contributes to both normal and oncogenic protein kinase signaling.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Coordinates have been deposited in the Protein
Data Bank under accession codes PDB 5CZI (Shc1 peptide) and PDB 5CZH (optimal peptide).
ONLINE METHODS
Positional scanning peptide library (PSPL) assay. Recombinant, wild-type and L858R EGFR kinase domains (residues 696-1022) and recombinant Src were generated as previously described 50, 51 . Recombinant ERRB2 was from Life Technologies, and recombinant ERBB4 was from SignalChem. The sequence of each of the 198 peptide libraries is G-A-X-X-X-Z-X-Y-X-X-X-X-A-G-K-Kbiotin (in which Z represents a fixed amino acid, and X represents an equimolar mixture of amino acids excluding tyrosine and cysteine). Aqueous stocks of each library were prepared in 50 mM HEPES, pH 7.4, and arrayed in 384-well plates containing 50 mM Tris, pH 7.5, 10 mM MgCl 2 , 10 mM MnCl 2 , and 2 mM DTT. Each row in the array contained libraries with a different fixed position relative to the central tyrosine, and in each column that position was fixed to a different amino acid. EGFR or Src and [γ-32 P]ATP was added to the wells, and the entire set of peptide libraries was phosphorylated in parallel at 30 °C for 1-2 h. The final concentrations of the reaction components were 50 µM peptide library, 200 nM EGFR or 70 nM Src, and 100 µM ATP with a specific activity of 1 mCi [γ-32 P]ATP/µmol, in a total volume of 10 µL. After the reactions had been allowed to proceed, 2-µL aliquots from each well were simultaneously transferred to an avidin-coated membrane (Promega SAM 2 biotin capture membrane) with a 384-slot pin replicator (VP Scientific). Membranes were washed sequentially with 0.1% SDS in TBS, 2 M NaCl + 1% H 3 PO 4 , and 2 M NaCl, and then dried. Phosphate incorporation into each library was quantified with a phosphorimager and the ImageQuant 5.2 software from Molecular Dynamics. The amount of phosphate incorporated into each well was divided by the average of all the wells in a row to determine the selectivity value for a given amino acid relative to the other residues at the same position. Therefore, values greater than 1 represent positive selections, and values less than 1 represent negative selections.
In vitro kinase assays. Peptides based on the sequences surrounding MET Tyr1234 (MYDKEYYSVHN) and Shc1 Tyr239 (PPDHQYYNDFP) were synthesized, HPLC purified, and verified by MS. Lysine residues were added to the C terminus of the peptides to ensure quantitative binding in phosphocellulose assays. The relative activity of EGFR or Src for each peptide was determined in reactions containing 100 nM EGFR or 100 nM Src, kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl 2 , 10 mM MnCl 2 , and 2 mM DTT), 200 µM ATP with a specific activity of 1 mCi [γ-32 P]ATP/µmol, and 400 µM peptide. After incubation at 30 °C for 30 min, aliquots of each reaction were spotted onto P81 phosphocellulose papers and washed extensively with 75 mM H 3 P0 4 . Filters were dried, and radioactivity was determined by scintillation counting. Values from control reactions in which the substrate peptide was omitted were subtracted from experimental values. All reactions were performed in triplicate.
For the HPLC analysis of the reaction products, the concentrations of EGFR and Src were adjusted to compensate for different specific activities. The final concentrations of the reaction components were 1 µM EGFR or 5 µM Src, 500 µM Shc1 peptide, and 1 mM ATP in a 100-µL reaction volume. For the reaction containing both Src and EGFR, the reaction was initiated by the addition of Src, and after a 60-min preincubation, EGFR was added. At various times, 25-µL aliquots of the reactions were removed and quenched with EDTA. Quenched aliquots were analyzed by HPLC on a 4.6 × 150 mM Agilent Eclipse Plus C18 column. Peptides were eluted with a 30-min linear gradient of 0-30% solvent B with a flow rate of 1.0 ml/min, in which solvent A was 0.1% trifluoroacetic acid, and solvent B was 0.1% trifluoroacetic acid in 100% acetonitrile. The elution profile was monitored by absorbance at 220 nm. The retention times of each peptide were established by individual injections under the same HPLC conditions. To identify the sites on the Shc1 peptide phosphorylated by EGFR or Src, the reaction products were analyzed by reversed-phase microcapillary/tandem MS (LC-MS/MS).
Kinetic parameters for EGFR phosphorylation of the Shc1 peptides were determined with the phosphocellulose assay. Increasing concentrations of peptide (0-12 mM) were incubated with 100 nM EGFR in kinase buffer supplemented with 2 µCi [γ-32 P]ATP/reaction for 30 min at 30 °C. Initial rates were determined from the linear portion of the reaction (<5% substrate consumption). Kinetic parameters were determined by fitting data to the Michaelis-Menten equation by use of nonlinear least-squares analysis of initial rates. Data shown are the average of three separate experiments, each performed in triplicate.
